丁胺卡那霉素(amikacin)是近年来新发现的一种半合成氨基甙类抗生素,对革兰氏阴性菌和葡萄球菌等有较强的抗菌活性,尤其是对庆大霉素、托普霉素耐药的绿脓杆菌、大肠杆菌、变形杆菌等敏感,且不易产生耐药性。为此,成都制药四厂试制了丁胺卡那霉素的新品种——丁胺卡那霉素外用溶液(丁胺)。为验证该药的疗效,我们采用双盲法对比研究治疗多种感染伤口共203例,其中资料完整者168例,兹分析报告如下: 对象及方法一、病例选择凡感染性伤口,伤口面积一般在3cm以内,感染时间不超过一个月,近两周内未用过抗生素,伤口分泌物 Amikacin is a semi-synthetic aminoglycoside antibiotic newly discovered in recent years. It has strong antibacterial activity against Gram-negative bacteria and Staphylococcus aureus, especially for gentamicin, Resistant to Pseudomonas aeruginosa, Escherichia coli, Proteus and other sensitive, and not easy to produce resistance. To this end, Chengdu Pharmaceutical Factory trial trial of a new variety of amikacin - amikacin topical solution (butylamine). To verify the efficacy of the drug, we use a double-blind comparative study of 203 cases of a variety of infected wounds, of which 168 cases of complete data, the analysis report is as follows: Subjects and methods First, the case selection Infectious wounds, wound area Within 3cm, the infection time does not exceed one month, the past two weeks have not been used antibiotics, wound secretions